226 related articles for article (PubMed ID: 22343407)
1. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.
Hodge JC; Kim TM; Dreyfuss JM; Somasundaram P; Christacos NC; Rousselle M; Quade BJ; Park PJ; Stewart EA; Morton CC
Hum Mol Genet; 2012 May; 21(10):2312-29. PubMed ID: 22343407
[TBL] [Abstract][Full Text] [Related]
2. Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis.
Hodge JC; Park PJ; Dreyfuss JM; Assil-Kishawi I; Somasundaram P; Semere LG; Quade BJ; Lynch AM; Stewart EA; Morton CC
Genes Chromosomes Cancer; 2009 Oct; 48(10):865-85. PubMed ID: 19603527
[TBL] [Abstract][Full Text] [Related]
3. HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies.
Gross KL; Neskey DM; Manchanda N; Weremowicz S; Kleinman MS; Nowak RA; Ligon AH; Rogalla P; Drechsler K; Bullerdiek J; Morton CC
Genes Chromosomes Cancer; 2003 Sep; 38(1):68-79. PubMed ID: 12874787
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.
Hodge JC; Quade BJ; Rubin MA; Stewart EA; Dal Cin P; Morton CC
Am J Pathol; 2008 May; 172(5):1403-10. PubMed ID: 18403592
[TBL] [Abstract][Full Text] [Related]
5. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features.
Christacos NC; Quade BJ; Dal Cin P; Morton CC
Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247
[TBL] [Abstract][Full Text] [Related]
6. The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata.
Xing YP; Powell WL; Morton CC
Cancer Genet Cytogenet; 1997 Oct; 98(1):69-74. PubMed ID: 9309121
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma.
Mello JBH; Barros-Filho MC; Abreu FB; Cirilo PDR; Domingues MAC; Pontes A; Rogatto SR
Mol Hum Reprod; 2018 Nov; 24(11):556-563. PubMed ID: 30376129
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyoma.
Ingraham SE; Lynch RA; Surti U; Rutter JL; Buckler AJ; Khan SA; Menon AG; Lepont P
Mutat Res; 2006 Dec; 602(1-2):43-53. PubMed ID: 17045619
[TBL] [Abstract][Full Text] [Related]
10. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
Hodge JC; Morton CC
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
[TBL] [Abstract][Full Text] [Related]
11. Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata.
Hayden MA; Ordulu Z; Gallagher CS; Quade BJ; Anchan RM; Middleton NR; Srouji SS; Stewart EA; Morton CC
Cancer Genet; 2018 Apr; 222-223():1-8. PubMed ID: 29666002
[TBL] [Abstract][Full Text] [Related]
12. The genetic heterogeneity of uterine leiomyomata.
Lobel MK; Somasundaram P; Morton CC
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):13-39. PubMed ID: 16504804
[TBL] [Abstract][Full Text] [Related]
13. Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele.
Hodge JC; T Cuenco K; Huyck KL; Somasundaram P; Panhuysen CI; Stewart EA; Morton CC
Hum Genet; 2009 Apr; 125(3):257-63. PubMed ID: 19132395
[TBL] [Abstract][Full Text] [Related]
14. Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas.
Nilbert M; Heim S; Mandahl N; Flodérus UM; Willén H; Mitelman F
Hum Genet; 1990 Oct; 85(6):605-11. PubMed ID: 2227952
[TBL] [Abstract][Full Text] [Related]
15. Translocations in 7q22 define a critical region in uterine leiomyomata.
Sargent MS; Weremowicz S; Rein MS; Morton CC
Cancer Genet Cytogenet; 1994 Oct; 77(1):65-8. PubMed ID: 7923086
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic abnormalities in uterine leiomyomata.
Rein MS; Friedman AJ; Barbieri RL; Pavelka K; Fletcher JA; Morton CC
Obstet Gynecol; 1991 Jun; 77(6):923-6. PubMed ID: 2030869
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.
Dimitrova IK; Richer JK; Rudolph MC; Spoelstra NS; Reno EM; Medina TM; Bradford AP
Fertil Steril; 2009 Jun; 91(6):2650-63. PubMed ID: 18672237
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis reveals an angiogenic profile in uterine leiomyoma pseudocapsule.
Di Tommaso S; Massari S; Malvasi A; Bozzetti MP; Tinelli A
Mol Hum Reprod; 2013 Jun; 19(6):380-7. PubMed ID: 23355533
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.
Klemke M; Meyer A; Nezhad MH; Bartnitzke S; Drieschner N; Frantzen C; Schmidt EH; Belge G; Bullerdiek J
Genes Chromosomes Cancer; 2009 Feb; 48(2):171-8. PubMed ID: 18980243
[TBL] [Abstract][Full Text] [Related]
20. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
